{"product_id":"cagrisema-5mg-plus-5mg","title":"Cagrisema 5mg + 5mg","description":"\u003ch2\u003eCagrisema — Research Peptide\u003c\/h2\u003e\n\u003cp\u003eCagrisema is a combination research peptide pairing \u003cstrong\u003eCagrilintide\u003c\/strong\u003e (amylin analog) with \u003cstrong\u003eSemaglutide\u003c\/strong\u003e (GLP-1 agonist) at 5 mg of each component per vial. It is one of the most studied combination peptide compounds within the comparative incretin–amylin research literature.\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% (HPLC-MS verified)\u003cbr\u003e\n  \u003cstrong\u003eFormat:\u003c\/strong\u003e 5mg + 5mg lyophilized vial, sealed amber glass\u003cbr\u003e\n  \u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\n\u003c\/p\u003e\n\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eCagrisema is supplied as a combination research formulation containing 5 mg of Cagrilintide and 5 mg of Semaglutide per vial. The pairing combines a long-acting amylin\/calcitonin receptor agonist with a selective GLP-1 receptor agonist, providing a single-vial reference compound for combination peptide research.\u003c\/p\u003e\n\n\u003cp\u003eWithin the published literature, Cagrisema is frequently positioned alongside dual unimolecular agonists such as Tirzepatide (GLP-1\/GIP) and Survodutide (GLP-1\/glucagon), and alongside the triple agonist Retatrutide, as part of the broader comparative multi-pathway incretin research lineage.\u003c\/p\u003e\n\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eCagrisema has been investigated in published research literature and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eCombination peptide pharmacology research\u003c\/li\u003e\n  \u003cli\u003eAmylin and GLP-1 receptor co-engagement research\u003c\/li\u003e\n  \u003cli\u003eComparative multi-pathway incretin research\u003c\/li\u003e\n  \u003cli\u003eCombination peptide pharmacokinetics and stability profiling\u003c\/li\u003e\n  \u003cli\u003eMetabolic signaling and satiety pathway models\u003c\/li\u003e\n  \u003cli\u003eReceptor binding affinity and selectivity studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCagrisema\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular class\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCombination research formulation (two synthetic peptides)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCombination amylin \/ GLP-1 receptor agonist research compound\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide family\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCombination incretin\/amylin research peptides\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCombination peptide pharmacology, amylin–GLP-1 co-administration research, metabolic signaling, comparative incretin research\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCagrilintide, Semaglutide, Tirzepatide, Retatrutide, Survodutide, Mazdutide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Cagrisema lot supplied by DISSOLV LABS undergoes a structured analytical workflow designed to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e5mg + 5mg lyophilized vial\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing white lyophilized solid\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-CAGSM-0010\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat is in a Cagrisema vial?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Cagrisema vial contains 5 mg of Cagrilintide and 5 mg of Semaglutide, supplied as a single co-lyophilized combination research formulation.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does Cagrisema differ from a unimolecular dual agonist like Tirzepatide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eTirzepatide is a single unimolecular peptide that engages two receptors. Cagrisema is a combination of two distinct peptides (Cagrilintide + Semaglutide) targeting amylin\/calcitonin and GLP-1 receptors respectively. They represent two distinct approaches to multi-pathway research within the incretin-amylin literature.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eDISSOLV LABS supplies Cagrisema at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS). Each lot is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Cagrisema lot is subjected to RP-HPLC purity analysis, HPLC-MS identity confirmation, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow should Cagrisema be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is Cagrisema reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eCagrisema is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs Cagrisema research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Cagrisema supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWho should handle Cagrisema?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eCagrisema is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSurvodutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eMazdutide\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCompliance\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"DISSOLV LABS","offers":[{"title":"Default Title","offer_id":52102992822552,"sku":"DSL-CAGSM-0010","price":37.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/Cagrisema_5mg_8c14bb10-2bbe-48da-89ca-20592ed9a76e.png?v=1779678436","url":"https:\/\/dissolv.com\/products\/cagrisema-5mg-plus-5mg","provider":"Dissolv Labs","version":"1.0","type":"link"}